Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-02-10 @ 7:14 PM
Study NCT ID:
NCT00215618
Status:
COMPLETED
Last Update Posted:
2009-01-14
First Post:
2005-09-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Uterine Balloon Treatment for Heavy Period Bleeding.
Sponsor:
Ethicon, Inc.
Organization:
Study Overview
Official Title:
Clinical Evaluation of Uterine Balloon Therapy System for Menorrhagia
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to determine the proportion of women who achieve permanent cessation of bleeding after Uterine Balloon Therapy (UBT) for the treatment of heavy uterine bleeding.
Detailed Description:
This study was also designed to determine the effect of a post procedure curettage on bleeding patterns and post-operative discharge and pain.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: